CTI Partners With LabWare for LIMS in Expanded Global Laboratory Services

Covington, KY — CTI Clinical Trial and Consulting Services (CTI), a global, full-service contract research organization (CRO) announces their partnership with LabWare, Inc., the global leader of Laboratory Information Management Systems (LIMS), Electronic Laboratory Notebook (ELN), and instrument integration solutions. CTI is working to expand laboratory services to support rare disease and cell & gene therapy research across all regions of the world, with a flagship lab being built in Cincinnati, OH (covering the Americas), and with the recent acquisition of Dynakin’s laboratory services to support Europe and the Middle East/Africa region.

The operation of a clinical laboratory requires accuracy and security of sensitive data. A laboratory information management system (LIMS) is a software-based solution that helps laboratories with data management and automation of processes, allowing facilities to effectively manage the flow of samples. The LIMS is a critical component of the laboratory, ensuring quality services by reducing paperwork, storing big data, and minimizing human errors.

“We are excited to partner with LabWare,” commented Dr. Tiffany Bratton, Laboratory Director at CTI. “They have been the gold standard in laboratory informatics solutions for more than 30 years and today serves >29,000 laboratories in >125 countries.”

CTI’s laboratory services include global service offerings with biorepository storage, kit building, safety testing, as well as novel assay development and validation. CTI’s laboratory services are led by a team of experts dedicated to providing the highest level of quality and customer satisfaction, with a focus on flexibility and complexities surrounding programs in regenerative medicine and rare diseases.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI is currently part of more than 30 active COVID-19 projects for treatment and prevention. CTI also offers a fully integrated multi-specialty clinical research site, as well as complete global laboratory services. Now in its third decade, it is one of the 20 largest CROs in the world with associates in more than 60 countries across six continents. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, MEA and Asia-Pacific. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations and for moving medicine forward. For more information visit www.ctifacts.com

 

< | >